ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification
Article in PLOS ONE (May 2024)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Article in PLOS ONE (May 2024)
Article in Heliyon (March 2024)
Article in Biochemical Genetics (March 2024)